Investigators leading ongoing pivotal trials in Alzheimer’s, multiple sclerosis, and stroke have had to make a quick pivot to change plans and protocols for key trials during the COVID-19 pandemic.

LEAVE A REPLY

Please enter your comment!
Please enter your name here